DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Sees Large Drop in Short Interest

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 9,890,000 shares, a decline of 28.2% from the October 31st total of 13,770,000 shares. Based on an average daily trading volume, of 3,100,000 shares, the short-interest ratio is presently 3.2 days. Approximately 5.0% of the company's shares are sold short.

DENTSPLY SIRONA Stock Up 0.1 %

XRAY stock traded up $0.01 on Friday, reaching $19.65. 1,289,234 shares of the company traded hands, compared to its average volume of 3,119,723. The firm has a fifty day simple moving average of $22.69 and a 200-day simple moving average of $24.85. The company has a market cap of $3.91 billion, a P/E ratio of -9.49, a price-to-earnings-growth ratio of 1.93 and a beta of 1.02. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $37.60. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same quarter in the previous year, the firm earned $0.49 EPS. DENTSPLY SIRONA's quarterly revenue was up .4% compared to the same quarter last year. Research analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on XRAY. Leerink Partners cut shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research note on Friday, November 8th. Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. Leerink Partnrs cut DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. Finally, StockNews.com lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $29.50.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors have recently added to or reduced their stakes in XRAY. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after purchasing an additional 753 shares in the last quarter. Capital Performance Advisors LLP bought a new position in DENTSPLY SIRONA during the 3rd quarter valued at about $27,000. LRI Investments LLC boosted its holdings in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after acquiring an additional 564 shares during the last quarter. Kennebec Savings Bank purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $35,000. Finally, Rothschild Investment LLC bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth approximately $32,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.